
Olay is owned by Procter and Gamble (NYSE: PG), the publicly traded American consumer goods corporation headquartered in Cincinnati, Ohio. P&G acquired Olay in 1985 through its purchase of Richardson-Vicks. The brand was founded in 1952 by South African chemist Graham Wulff as Oil of Olay. Olay generates an estimated $3 to $4 billion in annual revenue and is one of P&G's billion-dollar brands, sold in over 80 countries. P&G reported total net sales of $84.3 billion in fiscal year 2025.
Parent Company
Acquired
1985
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Olay | Procter & Gamble Company | Wholly owned |
Olay was founded in 1952 by Graham Wulff (1916-2008), a former Unilever chemist from Durban, South Africa. Wulff developed the product after his wife Dinah complained about the heavy, waxy beauty creams available at the time. He formulated a lighter, pink-tinted moisturizing fluid that absorbed into skin without leaving a greasy residue. Wulff named it "Oil of Olay" as a variation on "lanolin," a key ingredient in the formulation.
Wulff partnered with Jack Lowe, and together they ran the brand under Adams National Industries (ANI). Rather than selling directly to retailers, ANI waited for pharmacies to request the product based on consumer word-of-mouth. This unconventional distribution strategy built early demand through scarcity and recommendation.
As the brand expanded internationally, ANI adapted the name for different markets. The product was sold as Oil of Ulay in the United Kingdom and Ireland, Oil of Ulan in Australia, and Oil of Olaz in France, Germany, Italy, and the Netherlands. Each name was chosen to sound natural to local consumers.
In 1970, Richardson-Vicks Inc. acquired Adams National Industries. RVI added a dedicated sales force, created television advertising, and expanded the product range to include night creams and cleansers. RVI also opened a US test market in Chicago and expanded into northern Germany.
Procter and Gamble acquired Richardson-Vicks in 1985, bringing Olay into its portfolio. P&G expanded both the product line and international distribution significantly. The brand moved beyond basic moisturizers into treatment-focused skincare with scientifically positioned ingredients.
In 1999, P&G unified the brand name globally. Oil of Ulay, Oil of Ulan, and other regional names became simply "Olay" worldwide, except in German-speaking countries and Italy where it remained "Oil of Olaz" (later shortened to "Olaz"). The name change dropped the word "oil," which had acquired negative connotations for some consumers.
Olay introduced Total Effects in 2000, the first mass-market skincare range to feature niacinamide (vitamin B3) as a primary ingredient. Niacinamide strengthens the skin barrier and helps reduce visible signs of aging including tone, texture, enlarged pores, and dryness. The ingredient is now present across most Olay products.
In 2002, Olay launched Regenerist, the first mass-market skincare brand to use peptides. The Regenerist line features an Amino-Peptide Complex (PAL-KTTKS) that supports the skin's natural collagen production. P&G partnered with French company Sederma to develop the pentapeptide ingredient. The Regenerist launch was backed by an estimated $45 million marketing campaign, with first-year retail sales targets of $50 million.
The Regenerist Micro-Sculpting Cream became one of Olay's best-selling products. According to Nielsen IQ data, Olay's Regenerist line held the highest dollar share in mass-channel facial moisturizers for three consecutive years as of 2025.
Olay expanded its product lines throughout the 2010s and 2020s, adding Retinol24 (overnight retinoid treatment), Luminous (brightening), and Eyes (targeted eye care). The brand also introduced body care products and cleansers. In 2013, P&G reformulated the Regenerist line with Olivem, an olive oil derivative that protects skin cells.
Olay has faced growing competition from "clean beauty" brands like The Ordinary and Paula's Choice, which appeal to ingredient-educated consumers who read labels for specific active ingredient percentages. Olay's strategy has focused on its proprietary formulations and clinical backing, positioning its products as science-backed skincare at mass-market prices.
Procter & Gamble delivered mixed financial results in fiscal 2026, reflecting both the strength of its business model and challenges in the current consumer environment. In Q2 2026, P&G reported adjusted earnings per share of $1.88, exceeding Wall Street expectations of $1.86, while revenue of $22.21 billion fell slightly short of analyst expectations of $22.28 billion. The company's ability to beat earnings estimates despite revenue challenges demonstrates the effectiveness of its productivity initiatives and cost management strategies.
Financial Performance Overview shows P&G's resilience in a challenging market. The company revised its fiscal 2026 earnings outlook to 1% to 6% net earnings per share growth, down from the previous forecast of 3% to 9%, citing higher restructuring charges. Despite this adjustment, P&G maintained its sales growth guidance, reflecting confidence in its business fundamentals and strategic positioning. CFO Andre Schulten noted that "We've now completed what we fully expect will be the softest quarter of the fiscal year," indicating anticipation of improved performance in the second half.
Volume Performance revealed significant challenges across key categories, with overall volume falling 1% as three out of five product categories reported shrinking volume. This decline reflects broader consumer behavior patterns as inflation-weary consumers hunt for deals and reduce discretionary spending, particularly in P&G's largest market, the United States. Despite these challenges, Schulten emphasized that "People have not stopped washing their hair, they still buy diapers, they do their laundry — albeit at a little bit slower pace, so the market growth has certainly slowed over the last 18 to 24 months."
Segment Performance showed divergent trends across P&G's business portfolio. The baby, feminine and family care segment experienced the steepest decline with volume falling 5% in Q2 2026, facing tough comparisons with the year-ago period when retailers and consumers stocked up ahead of expected port strikes. The grooming business, which includes Gillette and Venus razors, reported a 2% volume drop, reflecting ongoing competitive pressures in the men's grooming market. The health-care segment saw volume fall 1%, including brands like Oral-B, Vicks, and Pepto-Bismol.
Bright Spots in Performance were primarily in the beauty segment, which was the only division to report volume growth, rising 3% fueled by stronger demand for hair-care products. The fabric and home-care business, which includes brands like Febreze and Tide, reported unchanged volume, demonstrating stability in P&G's largest business segment by revenue. These performance variations highlight the importance of P&G's diversified portfolio strategy in navigating market challenges.
Q1 2026 Results demonstrated stronger performance compared to Q2, with net sales of $22.4 billion, up 3% versus the prior year, and organic sales increasing 2%. The company achieved diluted EPS of $1.95 (up 21% YoY) and core EPS of $1.99 (up 3% YoY), reflecting strong operational execution. Operating cash flow was $5.4 billion, and the company returned $3.8 billion to shareholders through dividend payments and share repurchases, demonstrating P&G's commitment to shareholder returns.
Consumer Market Dynamics continue to shape P&G's performance, with the company facing "softer consumer markets, aggressive competition, and a dynamic geopolitical landscape" according to CFO Schulten. These challenges reflect broader economic pressures affecting consumer spending patterns and competitive intensity in key categories. However, P&G expects stronger results in the second half of the fiscal year, fueled by upcoming innovation and improved market conditions.
Innovation and Demand Creation remain central to P&G's strategy for driving growth. The company is increasing investment in innovation and demand creation to improve value for consumers and drive category growth. This focus on innovation is particularly important in the beauty segment, where new product development and marketing initiatives have helped drive volume growth despite overall market challenges.
Q3 2026 Results showed a significant acceleration in performance. P&G reported net sales of $21.24 billion, up 7% versus the prior year, beating Wall Street expectations of $20.5 billion. Organic sales increased 3%, driven by a 2% increase in volume — the first time in a year that P&G reported growing volume across the company. Core EPS of $1.59 beat estimates of $1.56, up 3% YoY. Diluted EPS was $1.63, up 6%, boosted by a gain from the dissolution of the Glad joint venture business. CEO Shailesh Jejurikar stated: "We delivered a solid acceleration in top-line results in our fiscal third quarter, with broad-based growth across product categories and regions." All five segments posted net sales growth: Beauty +11% ($3.87B), Fabric & Home Care +7% ($7.4B), Baby/Feminine/Family Care +6% ($5.06B), Health Care +7% ($3.07B), and Grooming +7% ($1.61B). The company returned $3.2 billion to shareholders via $2.5 billion in dividends and over $600 million in share repurchases. However, P&G warned about uncertainty from the Iran war's effects on input costs and consumer spending, projecting approximately $400 million in after-tax tariff costs and $150 million in commodity cost headwinds. If Brent crude stays around $100/barrel, P&G projects an annual after-tax headwind of $1 billion. The company will not provide a fiscal 2027 forecast until its July earnings report.
Leadership Transition Impact represents a significant element of P&G's current strategy. Shailesh Jejurikar's appointment as CEO effective January 1, 2026, brings fresh perspectives while maintaining continuity through Jon Moeller's transition to Executive Chairman. Jejurikar described his vision at the CAGNY Conference: leveraging P&G's strengths to "create the CPG company of the future."
Geographic Performance varied across P&G's global markets, with the United States facing particular challenges due to consumer behavior changes and competitive pressures. However, the company's global diversification provides stability, with different regions experiencing varying levels of economic pressure and consumer demand patterns.
Supply Chain and Operations have been optimized to support P&G's productivity initiatives and cost management strategies. The company's integrated supply chain encompasses suppliers, manufacturing partners, and retailers in complex networks ensuring product availability worldwide while maintaining operational efficiency.
Future Outlook remains cautiously optimistic, with P&G maintaining its fiscal year 2026 guidance for all-in sales growth of 1% to 5% and net EPS growth of 1% to 6% versus FY2025 diluted EPS of $6.51. Core EPS growth guidance is in-line to up 4% versus FY2025 core EPS of $6.83, equating to $6.83 to $7.09 per share. However, earnings are expected to trend toward the lower end of the range as cost headwinds persist and investments step up. The company faces approximately $400 million in after-tax tariff costs and $150 million in commodity cost headwinds. P&G will not provide a fiscal 2027 forecast until its July 2026 earnings report, citing uncertainty from the Iran war's impact on input costs and consumer spending.
Investor Confidence remained strong despite mixed results, with P&G shares rising more than 2% in morning trading following the Q2 earnings announcement. This positive market response reflects investor confidence in P&G's ability to navigate current challenges while positioning for future growth through strategic initiatives and operational excellence.
P&G's recent performance demonstrates the company's ability to maintain profitability and shareholder returns while navigating challenging market conditions. The combination of operational efficiency, brand strength, and strategic focus on innovation provides a solid foundation for continued success in the competitive consumer goods industry.
Olay is not certified cruelty-free. The brand sells products in mainland China, where animal testing is required by law for certain imported cosmetics. PETA lists Olay and Procter and Gamble on its "companies that test on animals" list. P&G states that it does not test products on animals unless required by law, and the company has invested in developing alternative testing methods. However, the legal requirement in China means Olay products sold there are subject to animal testing.
Olay is not certified vegan. Some products may contain animal-derived ingredients such as beeswax, lanolin, or carmine. The brand does not carry a vegan certification from The Vegan Society or any other recognized certifying body.
Olay has partnered with Coursera to provide 5,000 scholarships from 2024 to 2026, focused on STEM education. The program specifically supports students from Historically Black Colleges and Universities (HBCUs). This initiative is part of Olay's broader commitment to advancing women in STEM fields.
P&G has set corporate sustainability targets including carbon neutrality for operations, 100% recyclable or reusable packaging, and water conservation in manufacturing. Olay participates in these corporate initiatives but does not publish brand-specific sustainability metrics.
Animal Testing: Olay has faced sustained criticism from animal welfare organizations including PETA and Humane Society International for selling products in markets that require animal testing. While P&G has invested in alternative testing methods and advocates for regulatory change, the brand's continued presence in mainland China means its products are subject to animal testing under Chinese law. PETA lists Olay on its "companies that test on animals" database.
Ingredient Safety Concerns: Olay has faced consumer scrutiny regarding certain ingredients historically used in its formulations, including parabens and phthalates. Consumer advocacy groups including the Environmental Working Group have flagged these ingredients in their cosmetic safety databases. Olay has reformulated some products to remove controversial ingredients in response to consumer pressure, though the brand has not adopted a "clean beauty" formulation standard.
Greenwashing Allegations: Some consumer advocates have questioned whether Olay's sustainability marketing claims are sufficient given the scale of its operations and the environmental impact of mass-produced skincare packaging. The brand has been criticized for plastic packaging waste, though P&G has committed to making 100% of its packaging recyclable or reusable by 2030.
Competition from Clean Beauty: Olay faces increasing pressure from clean beauty brands and indie skincare companies that challenge traditional formulations and marketing approaches. Brands like The Ordinary and Paula's Choice have captured ingredient-educated consumers by offering transparent ingredient lists and clinical formulations at competitive prices. This competitive pressure has forced Olay to adapt its marketing to emphasize clinical research and ingredient science.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Unknown | USA | 1957 | Mass market | Global | All Genders | |
| Unilever | United Kingdom | 1957 | Mass market | Global | Womens | |
| Loreal | France | 1909 | Market leader | Global | All Genders | |
| Kenvue | USA | 1930 | Mass market | Global | All Genders | |
| Unilever | USA (Elida Beauty) | 1914 | Mass market | United states | Unisex | |
| Unilever | United Kingdom | 1846 | Mass market | Global | Womens |
Beauty Personal CareOwned by Unknown Company
French-American dermatological skincare brand specializing in anti-aging and retinol formulations, owned by Bridgepoint Group.
Beauty Personal CareOwned by Unilever plc
Personal care brand owned by Unilever, known for beauty bars and skincare products. Over $5 billion in annual revenue.
Beauty Personal CareOwned by L'Oréal S.A.
L'Oréal Group flagship mass-market beauty brand, sold in over 150 countries. Skincare, haircare, makeup, and hair colour products.
Beauty Personal CareOwned by Kenvue
Dermatologist-recommended skincare brand owned by Kenvue, specializing in cleansers, acne treatments, sun protection, and anti-aging products.
Beauty Personal CareOwned by Unilever plc
American skincare brand founded in 1914 and known for its medicated deep cleansing cream. Owned by Elida Beauty, a Yellow Wood Partners portfolio company, since June 2024. Previously owned by Unilever (2010-2024), Alberto-Culver (2008-2010), and Procter & Gamble (1989-2008).
Beauty Personal CareOwned by Unilever plc
Global mass-market skincare brand owned by Unilever, founded in 1846 and known for cold cream, vanishing cream, and affordable skincare products sold in over 50 countries.
Market Positioning: Olay competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Procter & Gamble Company, giving you alternative choices that support different corporate structures.
Beauty Personal CareOwned by Evyap
Turkish beauty and bath soap brand manufactured by Evyap. Sold in over 100 countries. Known for natural ingredients including olive oil, shea butter, and coconut. Market leader in Eastern Europe and Central Asia.
Duru is privately owned, unlike Olay which is under a publicly traded parent company.
Beauty Personal CareOwned by Unknown Company
French-American dermatological skincare brand specializing in anti-aging and retinol formulations, owned by Bridgepoint Group.
RoC is privately owned, unlike Olay which is under a publicly traded parent company.
Beauty Personal CareOwned by Evyap
Turkish brand of men's grooming and shaving products manufactured and marketed by Evyap, known for affordable quality shaving soaps.
Arko is privately owned, unlike Olay which is under a publicly traded parent company.
Beauty Personal CareOwned by Nexus Capital Management
American direct-to-consumer razor and grooming brand known for its subscription model and viral marketing.
Dollar Shave Club is privately owned, unlike Olay which is under a publicly traded parent company.
Beauty Personal CareOwned by Evyap
Mass-market soap and personal care brand owned by Evyap, sold in over 100 countries with strong positions in Eastern Europe and the Middle East.
Fax is privately owned, unlike Olay which is under a publicly traded parent company.
Beauty Personal CareOwned by Evyap
Men's personal care and grooming brand owned by Evyap, a privately held Turkish personal care company founded in 1927. Gibbs offers shaving products, deodorants, and grooming items primarily in European, Middle Eastern, and Central Asian markets.
Gibbs is privately owned, unlike Olay which is under a publicly traded parent company.
Discover popular brands and companies in the Beauty & Personal Care category and related searches from other users.

Italian luxury fragrance and grooming brand founded in Parma in 1916, owned by LVMH since 2001. Known for its signature Colonia fragrance and a full range of home and lifestyle products made in Italy.

Turkish antibacterial soap and personal hygiene brand owned by Evyap, one of Turkey's largest consumer goods manufacturers. Activex uses silver ion technology and is sold primarily in Turkey and Middle Eastern markets.

Procter & Gamble's feminine hygiene brand launched in 1983, holding approximately 27% global market share in menstrual pads and sold in more than 100 countries.